Novel small-molecule NOP receptor antagonists were designed, prepared, and evaluated.
Compound 15 exhibited high potency and high selectivity as a NOP receptor antagonist.
Contributing-factors for potency/selectivity of NOP receptor antagonist are suggested.
Contributing-factors for metabolic stability are suggested.
Contributing-factors for reducing hERG channel binding affinity are suggested.